KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Short term Debt (2016 - 2020)

Neogenomics (NEO) has disclosed Short term Debt for 11 consecutive years, with $5.0 million as the latest value for Q1 2020.

  • For the quarter ending Q1 2020, Short term Debt fell 36.49% year-over-year to $5.0 million, compared with a TTM value of $5.0 million through Mar 2020, down 36.49%, and an annual FY2019 reading of $5.0 million, down 36.49% over the prior year.
  • Short term Debt was $5.0 million for Q1 2020 at Neogenomics, roughly flat from $5.0 million in the prior quarter.
  • Across five years, Short term Debt topped out at $7.9 million in Q4 2018 and bottomed at $596000.0 in Q1 2016.
  • Average Short term Debt over 5 years is $4.5 million, with a median of $4.2 million recorded in 2018.
  • The sharpest move saw Short term Debt skyrocketed 581.82% in 2016, then crashed 36.49% in 2019.
  • Year by year, Short term Debt stood at $3.8 million in 2016, then changed by 0.0% to $3.8 million in 2017, then surged by 109.95% to $7.9 million in 2018, then plummeted by 36.49% to $5.0 million in 2019, then changed by 0.0% to $5.0 million in 2020.
  • Business Quant data shows Short term Debt for NEO at $5.0 million in Q1 2020, $5.0 million in Q4 2019, and $6.2 million in Q3 2019.